SCHEMBL3375880

SCHEMBL3375880

NC(=O)C12CC3CC(CC(NC(=O)c4cccc(OC(F)F)c4)(C3)C1)C2

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.73
ATM Q13315 1/20 0.73
FAAH O00519 4/20 0.56
CNR2 P34972 4/20 0.56
MEN1 O00255 3/20 0.56
EPHX2 P34913 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.44
NPSR1 Q6W5P4 3/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 2/20 0.43
PKM P14618 1/20 0.43
LMNA P02545 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
STS P08842 1/20 0.41
HSD11B1 P28845 1/20 0.41
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2638886 0.88 FAAH (0.73) KMT2AATMFAAHCNR2MEN1
SCHEMBL3375884 0.87 KMT2A (0.77) KMT2AATMFAAHCNR2MEN1
SCHEMBL3375698 0.85 FAAH (0.56) KMT2AATMFAAHCNR2MEN1
SCHEMBL2638957 0.85 KMT2A (1.00) KMT2AATMFAAHCNR2MEN1
SCHEMBL2638075 0.85 FAAH (0.55) KMT2AATMFAAHCNR2MEN1
SCHEMBL2638487 0.84 GRM5 (0.53) KMT2AATMFAAHCNR2MEN1
SCHEMBL3378038 0.84 FAAH (0.54) KMT2AATMFAAHCNR2MEN1
SCHEMBL3376419 0.83 FAAH (0.70) KMT2AATMFAAHCNR2MEN1
SCHEMBL3377748 0.82 FAAH (0.52) KMT2AATMFAAHCNR2MEN1
SCHEMBL3377735 0.82 FAAH (0.53) KMT2AATMFAAHCNR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2310356-B1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME LUNDBECK & CO AS H (DK) 2013-08-14 EP claimed
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2010-01-28 US claimed
US-8716284-B2 Adamantyl diamide derivatives and uses of same H. LUNDBECK A/S (DK) 2014-05-06 US disclosed
US-20130184277-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2013-07-18 US disclosed
US-8389519-B2 Adamantyl diamide derivatives and uses of same H. LUNDBECK A/S (DK) 2013-03-05 US disclosed
US-20120270873-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2012-10-25 US disclosed
US-8198275-B2 Adamantyl diamide derivatives and uses of same H. LUNDBECK A/S (DK) 2012-06-12 US disclosed
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270873-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME QDPR, PDE3B, ADM2 KMT2A 3173/4885ATM 2759/4885FAAH 2836/4885
US-20130184277-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME QDPR, PDE3B, ADM2 KMT2A 2991/4885ATM 2972/4885FAAH 2727/4885
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME QDPR, ADM2, PDE3B KMT2A 3089/4885ATM 2684/4885FAAH 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.